Xeris Biopharma Holdings, Inc. (XERS) SEC Filings — 2025
11 SEC filings for Xeris Biopharma Holdings, Inc. (XERS) in 2025.
Filings
- Xeris Biopharma Files 8-K — 8-K · Dec 1, 2025
- Xeris Biopharma Revenue Soars, Narrows Losses in Q3 — 10-Q · Nov 6, 2025
- Xeris Biopharma Q2 Revenue Jumps 24.8% on Strong Product Sales — 10-Q · Aug 7, 2025
- Xeris Biopharma Holdings Files 8-K on Shareholder Votes — 8-K · Jun 4, 2025
- Xeris Biopharma Files 8-K Report — 8-K · Jun 3, 2025
- Xeris Biopharma Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Xeris Biopharma Files 2024 Executive Compensation Details — DEF 14A · Apr 23, 2025
- Xeris Biopharma Files 8-K on Executive Changes — 8-K · Mar 28, 2025
- Xeris Biopharma Holdings, Inc. 10-K Filing — 10-K · Mar 6, 2025
- Xeris Biopharma Files 8-K: Director Changes & Compensation — 8-K · Feb 24, 2025
- Xeris Biopharma Files 8-K on Financials — 8-K · Jan 10, 2025